4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000085
CEO bought 7,500 shares at an average $0.12 ($932)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-07-22 | Purchase : show line 1 in the form | +6,400 | $0.13 | $800 | 7,107,019 | D |
| 2016-07-22 | Purchase : show line 2 in the form | +1,100 | $0.12 | $132 | 7,108,119 | D |
| Open-market purchases · 7,500 sh · avg $0.12 · $932 | ||||||
Loading xslF345X03/primary_doc.xml…